The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; none of the 43 sources its claims cite is checked for support yet.
The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis
Open accessAbstract
Background: This systematic review aimed to evaluate the efficacy of medical-grade honey (MGH) in eliminating and inhibiting Pseudomonas aeruginosa (P. aeruginosa) biofilms, which are known for their resistance to conventional antibiotics and significant role in chronic infections. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines and registered in PROSPERO (CRD42024614542), a systematic search was conducted across PubMed, ProQuest, Scopus, and EBSCO using terms related to P. aeruginosa, biofilm, and MGH. Inclusion criteria encompassed in vitro studies assessing MGH’s effect on P. aeruginosa biofilms, with reported outcomes including biofilm inhibition and eradication. Data extraction and risk-of-bias assessment were performed independently by two reviewers using the Quality Assessment Tool for In Vitro Studies (QUIN) tool. Publication bias was estimated through forest plot. Results: A total of 1,934 records were identified from four databases. After screening and full-text review, six in vitro studies met the inclusion criteria for qualitative synthesis, and five were eligible for meta-analysis. All studies evaluated the effect of MGH, including Manuka and Surgihoney, on P. aeruginosa biofilms using crystal violet staining and spectrophotometric analysis. Pooled results showed that MGH significantly reduced biofilm formation (standardized mean difference (SMD) = -4.98; 95% confidence interval (CI): -6.72 to -3.25) and effectively disrupted established biofilms (SMD = -4.44; 95% CI: -6.62 to -2.26). Subgroup analysis revealed stronger effects on American Type Culture Collection (ATCC) strains than clinical isolates, with low within-subgroup heterogeneity. MGH also demonstrated significant superiority compared to active biofilm controls, although sterility control comparisons showed high variability. Mechanistic analysis found that Medihoney outperformed sugar solutions and methylglyoxal (MGO) alone, suggesting that its antibiofilm activity results from synergistic bioactive compounds. Overall, these findings support MGH as a potent antibiofilm agent, warranting further research for clinical application against P. aeruginosa biofilm infections. Conclusion: MGH exhibits consistent and substantial anti-biofilm activity against P. aeruginosa in vitro, affecting both biofilm formation and established biofilms. These findings support its potential application as a topical therapeutic agent in managing biofilm-related infections, particularly in chronic wounds. Future research should prioritize standardized application protocols and investigate synergistic effects with conventional antimicrobials through clinical trials.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis found that medical-grade honey (MGH) significantly reduces *Pseudomonas aeruginosa* biofilm formation and disrupts established biofilms in vitro. Pooled standardized mean differences were -4.98 for biofilm formation and -4.44 for established biofilms, with stronger effects reported for ATCC strains than clinical isolates.
Key findings
- Across five in vitro studies, MGH significantly reduced *P. aeruginosa* biofilm formation: pooled SMD = -4.98 (95% CI: -6.72 to -3.25, P < 0.0001), with moderate heterogeneity (I² = 32.3%).
- Across three studies, MGH significantly disrupted established biofilms: pooled SMD = -4.44 (95% CI: -6.62 to -2.26, P < 0.0001), with low heterogeneity (I² = 12.7%).
- Subgroup analysis found a stronger effect on ATCC strains than clinical isolates (reported in the discussion as SMD = -31.79 vs -4.35; subgroup difference χ² = 23.90, P < 0.0001). Active biofilm controls showed significant inhibition (pooled SMD = -5.80, 95% CI: -8.26 to -3.35), while sterility controls were not statistically significant (pooled SMD = -14.83, 95% CI: -42.01 to 12.34, I² = 94%).
- Mechanistic analysis indicated Medihoney outperformed sugar solutions and methylglyoxal alone, suggesting synergistic bioactive compounds; all six included studies scored >80% on the QUIN tool, indicating low risk of bias.
Methods
- PRISMA-guided systematic review registered in PROSPERO (CRD42024614542); searched PubMed, ProQuest, Scopus, and EBSCO. Inclusion criteria were English-language in vitro studies of MGH against *P. aeruginosa* biofilms, published after 2000; 1,934 records were identified, 33 full texts reviewed, six studies included qualitatively, and five in the meta-analysis.
- Two reviewers independently extracted data and assessed risk of bias using the QUIN tool. Outcomes were based on crystal violet staining and spectrophotometric optical density; numerical data were digitized with WebPlotDigitizer and transformed to standardized mean differences (SMDs).
- Meta-analysis used R 4.3.2 with the “meta” and “metafor” packages, a fixed-effect model, 95% confidence intervals, and heterogeneity assessed with I²; statistical significance was set at P < 0.05.
Limitations
- The paper states that all included studies were in vitro and used static biofilm models, which do not fully replicate host immune response, tissue penetration, or wound exudate dynamics; dynamic models may be more clinically relevant, so extrapolation to in vivo efficacy should be cautious.
- The paper states that the meta-analysis on established biofilms included only three studies, limiting statistical power; control group methodologies varied, honey concentrations and exposure durations ranged widely, and MGH formulations differed in viscosity, making optimal treatment protocols unclear.
- The paper states that none of the included studies reported randomization, blinding, or operator/outcome-assessor details, and QUIN was originally validated in dentistry; publication bias was assessed visually with funnel plots rather than formal statistical testing.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 37 Not checked · 71 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, the prediction interval ranged from -65.89 to 28.20, suggesting potential variability in future studies, particularly under differing experimental conditions.”
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Results > Extraction outcome
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Heterogeneity was moderate (I2 = 44.5%), reflecting more consistent findings across studies.”
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Results > Extraction outcome
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Among the individual studies, Halstead et al [28] reported a robust inhibitory effect (SMD = -7.44; 95% CI: -11.20 to -3.68)”
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Results > Extraction outcome
What the sources say
- Not checked yetcites [28] Halstead FD Webber MA Rauf M Burt R Dryden M Oppenheim BA In vitro activity of an engineered honey, medical-grade honeys, and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates J Wound Care 2016 25 4 93 102 10.12968/jowc.2016.25.2.93 26878302
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 3 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of heterogeneity yielded an I2 statistic of 32.3%, a between-study variance (Tau2) of 2.3897, and a non-significant Cochran’s Q test (P = 0.2064), suggesting moderate but not substantial variability in effect sizes across studies.”
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Results > Extraction outcome
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“MGH also demonstrated significant superiority compared to active biofilm controls, although sterility control comparisons showed high variability.”
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
44 more claims
Create a free account to see all 108 claims and to verify the 29 references still open.
- It may state two separate claims as one. 45
- The quote only partly states this claim. 1
- Probably not a substantial claim. 15
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Results > Quality assessment
“Based on evaluation using the QUIN tool, all studies achieved scores exceeding 80%, signifying a low risk of bias.”
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Results > Quality assessment
“| 11 | Statistical analysis | The studies use valid statistical tests (e.g., t-test, ANOVA). | 2 | 0 | 1 | 2 | 1 | 2 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Results > Extraction outcome
“The pooled SMD was 31.79 (95% CI: -42.60 to -20.98), indicating a large and statistically significant reduction in biofilm biomass compared to control treatments.”
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Discussion > Key findings and explanation
“The effect on ATCC strains was found to be substantially stronger (SMD = -31.79) compared to clinical isolates (SMD = -4.35).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Results > Quality assessment
“| Cooper et al, 2014 [23] |”
§ The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis > Results > Study characteristics
“| 2 | Cooper et al, 2014 [27] |”
Citations
Cites
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Pseudomonas genomes: diverse and adaptable
Silby, M. W., Winstanley, C., Godfrey, S. A. C., Levy, S. B., & Jackson, R. W. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00269.x · Cited by 960
Pseudomonas aeruginosa Biofilms
Thi, M. T. T., Wibowo, D., & Rehm, B. H. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228671 · Cited by 911
Honey: its medicinal property and antibacterial activity
Mandal, M. D., & Mandal, S. (2011) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(11)60016-6 · Cited by 893
Carmeli, Y., Troillet, N., Eliopoulos, G. M., & Samore, M. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1379 · Cited by 650
Sheth, V. H., Shah, N. P., Jain, R., Bhanushali, N., & Bhatnagar, V. (2024) · The Journal of Prosthetic Dentistry · doi:10.1016/j.prosdent.2022.05.019 · Cited by 440 · cited 3×
“Although no universally accepted standard exists for evaluating the quality of in vitro studies, this review employed the Quality Assessment Tool for In Vitro Studies (QUIN) (Terna Dental College, Mumbai, India) [25], a framework originally developed in the field of prosthetic dentistry.”
InfluentialThe antibacterial activities of honey
Almasaudi, S. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.10.017 · Cited by 425
Srinivasan, R., Santhakumari, S., Poonguzhali, P., Geetha, M., Dyavaiah, M., & Xiangmin, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.676458 · Cited by 352
Honey for Wound Healing, Ulcers, and Burns; Data Supporting Its Use in Clinical Practice
Al-Waili, N., Salom, K., & Al-Ghamdi, A. A. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.78 · Cited by 314
Oryan, A., Alemzadeh, E., & Moshiri, A. (2016) · Journal of Tissue Viability · doi:10.1016/j.jtv.2015.12.002 · Cited by 309
Yaghoobi, R., Kazerouni, A., & kazerouni, O. (2013) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.17795/jjnpp-9487 · Cited by 256
Honey and Microbial Infections: A Review Supporting the Use of Honey for Microbial Control
Al-Waili, N. S., Salom, K., Butler, G., & Al Ghamdi, A. A. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2010.0161 · Cited by 226
Advances in the Sensing and Treatment of Wound Biofilms
Darvishi, S., Tavakoli, S., Kharaziha, M., Girault, H. H., Kaminski, C. F., & Mela, I. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202112218 · Cited by 199
Treatment of Pseudomonas aeruginosa infectious biofilms: Challenges and strategies
Yin, R., Cheng, J., Wang, J., Li, P., & Lin, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.955286 · Cited by 187
Biofilm formation: mechanistic insights and therapeutic targets
Wang, X., Liu, M., Yu, C., Li, J., & Zhou, X. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00164-w · Cited by 173
Streeter, K., & Katouli, M. (2016) · Infection Epidemiology and Medicine · doi:10.18869/modares.iem.2.1.25 · Cited by 167
Quality assessment tools used in systematic reviews of in vitro studies: A systematic review
Tran, L., Tam, D. N. H., Elshafay, A., Dang, T. B., Hirayama, K., & Huy, N. T. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01295-w · Cited by 163
Alnuaimi, A. D., O’brien-simpson, N. M., Reynolds, E. C., & McCullough, M. J. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12068 · Cited by 99
Honey can inhibit and eliminate biofilms produced by Pseudomonas aeruginosa
Lu, J., Cokcetin, N. N., Burke, C. M., Turnbull, L., Liu, M., Carter, D. A., Whitchurch, C. B., & Harry, E. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-54576-2 · Cited by 92
Morroni, G., Álvarez-Suárez, J. M., Brenciani, A., Simoni, S., Fioriti, S., Pugnaloni, A., Giampieri, F., Mazzoni, L., Gasparrini, M., Marini, E., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01378 · Cited by 86
Marin, F., Rohatgi, A., & Charlot, S. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1708.02025 · Cited by 78
Halstead, F. D., Webber, M. A., Rauf, M., Burt, R., Dryden, M., & Oppenheim, B. A. (2016) · Journal of Wound Care · doi:10.12968/jowc.2016.25.2.93 · Cited by 74
Kamaruzzaman, N. F., Peng, T. L., Yazid, K. A. M., Saeed, S. I., Hamdan, R. H., Choong, S. S., Wong, W. K., Chivu, A., & Gibson, A. J. (2018) · Materials · doi:10.3390/ma11091705 · Cited by 69
Pleeging, C. C. F., Coenye, T., Mossialos, D., de Rooster, H., Chrysostomou, D., Wagener, F. A. D. T. G., & Cremers, N. A. J. (2020) · Antibiotics · doi:10.3390/antibiotics9120866 · Cited by 63
Manuka Honey Inhibits Adhesion and Invasion of Medically Important Wound Bacteria in Vitro
Maddocks, S. E., Jenkins, R. E., Rowlands, R. S., Purdy, K. J., & Cooper, R. A. (2013) · Future Microbiology · doi:10.2217/fmb.13.126 · Cited by 61
Lerrer, B., Zinger-Yosovich, K. D., Avrahami, B., & Gilboa‐Garber, N. (2007) · The ISME Journal · doi:10.1038/ismej.2007.20 · Cited by 56
Inhibition of biofilms of Pseudomonas aeruginosa by Medihoney in vitro
Cooper, R., Jenkins, L., & Hooper, S. (2014) · Journal of Wound Care · doi:10.12968/jowc.2014.23.3.93 · Cited by 44
Wang, R., Starkey, M., Hazan, R., & Rahme, L. G. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00144 · Cited by 44
Camplin, A. L., & Maddocks, S. (2014) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-13-19 · Cited by 44
Relevance of Biofilm Models in Periodontal Research: From Static to Dynamic Systems
Sánchez, M. C., Alonso-Español, A., Ribeiro-Vidal, H., Alonso, B., Herrera, D., & Sanz, M. (2021) · Microorganisms · doi:10.3390/microorganisms9020428 · Cited by 39
Evaluating models and assessment techniques for understanding oral biofilm complexity
Ramachandra, S. S., Wright, P. P., Han, P., Abdal‐hay, A., Lee, R. S. B., & Ivanovski, S. (2023) · MicrobiologyOpen · doi:10.1002/mbo3.1377 · Cited by 35
Cendra, M. D. M., & Torrents, E. (2020) · Virulence · doi:10.1080/21505594.2020.1787034 · Cited by 27
Ng, W. J., Matejczuk, K., Ee, K. Y., Boutrou, I., Hew, P. S., Szweda, P., & Mossialos, D. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106967 · Cited by 8
Cited by
Aromatic profiles and 15-LOX inhibitory effects of Australian and New Zealand Manuka honeys
Moore, G., Boufridi, A., Russell, F. D., & Brooks, P. (2026) · PLoS ONE · doi:10.1371/journal.pone.0361877
Metadata
- Authors
- Hariyudo, H., Benokri, H. R., Wirohadidjojo, Y. W., Herdini, C., Budiyanto, A., & Nugroho, D. B.
- Affiliations
- Universitas Gadjah Mada (ID)
- Corresponding author
- Hariyudo, Hariyudo
- Venue
- Journal of Clinical Medicine Research
- Publisher
- Elmer Press, Inc.
- Published
- 2025-08
- Volume
- 17
- Issue
- 8
- Pages
- 445-459
- ISSN
- 1918-3003 (ISSN-L)
- 1918-3011
- PMC
- PMC12434934
- OpenAlex
- W4413907042
- Semantic Scholar
- 68e4eb3aa835d0412395a8322b62ce41898389b8
- Cited by
- 1
- References
- 35
- Citations by year
- 2026: 1
- FWCI
- 0.09
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Insect Science › Bee Products Chemical Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Agricultural and Biological Sciences › Food Science › Essential Oils and Antimicrobial Activity
- Keywords
- medical-grade honey, Pseudomonas aeruginosa, biofilm eradication, biofilm inhibition, antibiofilm activity, manuka honey, methylglyoxal, chronic infection, biofilm-associated infections, wound healing, wound infection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.